Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- David Miklos
- Target Recruit Count
- 15
- Registration Number
- NCT00760981
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, United States
News
No news found